NVIDIA and Microsoft are joining forces to accelerate artificial intelligence startups globally, with an initial focus on healthcare and life sciences companies. The initiative combines NVIDIA’s Inception program for cutting-edge startups with Microsoft for Startups, providing innovators with access to accelerated computing, cloud credits, software for AI development, and technical and business expertise.
In the first phase, high-potential digital health and life sciences companies will receive $150,000 in Microsoft Azure credits, up to $200,000 worth of Microsoft business tools, and priority access to its Pegasus Program for go-to-market support. NVIDIA Inception will provide 10,000 ai.nvidia.com inference credits, preferred pricing on NVIDIA AI Enterprise, early access to new healthcare offerings, and opportunities to connect with investors and industry partners.
Companies like Artisight, which uses AI to improve operational efficiency in hospitals, and Pangaea Data, which helps identify undertreated patients, are already benefiting from the collaboration. Other startups participating in both programs include Artificial, BeeKeeperAI, and Niramai, all of which are leveraging NVIDIA GPUs on Azure to advance their work. Key individuals involved include Andrew Gostine, founder and CEO of Artisight, and Vibhor Gupta, CEO of Pangaea Data.
Accelerating AI Innovation in Healthcare and Life Sciences
NVIDIA and Microsoft are expanding their collaboration to support global AI startups across industries, with an initial focus on healthcare and life sciences companies. This initiative connects the startup ecosystem by bringing together the NVIDIA Inception global program for cutting-edge startups and Microsoft for Startups, providing innovators with accelerated computing, cloud credits, software for AI development, and technical and business expert support.
The first phase of this collaboration will focus on high-potential digital health and life sciences companies that are part of both programs. Future phases will expand to startups in other industries. Microsoft for Startups will provide each company with $150,000 of Microsoft Azure credits, up to $200,000 worth of Microsoft business tools, and priority access to its Pegasus Program for go-to-market support. NVIDIA Inception will offer 10,000 ai.nvidia.com inference credits, preferred pricing on NVIDIA AI Enterprise, early access to new NVIDIA healthcare offerings, and opportunities to connect with investors and industry partners.
Supporting Startups at Every Stage
Hundreds of companies are already part of both NVIDIA Inception and Microsoft for Startups, leveraging the combination of accelerated computing infrastructure and cutting-edge AI to advance their work. For example, Artisight, a smart hospital startup, uses AI to improve operational efficiency, documentation, and care coordination in hospitals. Its products utilize software including NVIDIA Riva for conversational AI, NVIDIA DeepStream for vision AI, and NVIDIA Triton Inference server to simplify AI inference in production.
Artisight’s founder and CEO, Andrew Gostine, emphasized the importance of access to the latest AI technologies in developing reliable smart hospital solutions. Similarly, Pangaea Data, a company helping healthcare organizations identify undertreated or untreated patients, uses NVIDIA GPUs on Azure’s HIPAA-compliant cloud environment and the NVIDIA FLARE federated learning framework to preserve patient privacy while driving improvement in health outcomes.
Building on a Trove of Healthcare Resources
Microsoft and NVIDIA’s collaboration aims to support projects in clinical research, drug discovery, medical imaging, and precision medicine. This partnership brings together Microsoft Azure with NVIDIA DGX Cloud, an end-to-end, scalable AI platform for developers. It also provides users of NVIDIA DGX Cloud on Azure access to NVIDIA Clara, including domain-specific resources such as NVIDIA BioNeMo, a generative AI platform for drug discovery; NVIDIA MONAI, a suite of enterprise-grade AI for medical imaging; and NVIDIA Parabricks, a software suite designed to accelerate processing of sequencing data for genomics applications.
Empowering Startups with Advanced AI Capabilities
Other startups participating in both programs and using NVIDIA GPUs on Azure include Artificial, a lab orchestration startup exploring the use of NVIDIA BioNeMo for drug discovery; BeeKeeperAI, which enables secure computing on sensitive data; and Niramai, a startup that has developed an AI-powered medical device for early breast cancer detection. These startups demonstrate the potential of AI innovation in healthcare and life sciences, and the importance of collaborations like NVIDIA and Microsoft’s in supporting these efforts.
By providing access to advanced AI capabilities, cloud infrastructure, and expert support, this collaboration aims to accelerate the development of innovative solutions that can transform the healthcare and life sciences industries. As the startup ecosystem continues to grow, initiatives like this will play a critical role in driving progress and improving patient outcomes.
External Link: Click Here For More
